Literature DB >> 8596736

Activation of the hyperpolarization-activated current (if) in sino-atrial node myocytes of the rabbit by vasoactive intestinal peptide.

E A Accili1, G Redaelli, D DiFrancesco.   

Abstract

Vasoactive intestinal peptide (VIP) is a putative neurotransmitter found in extrinsic and intrinsic nerves of the heart. VIP can be released by vagal stimulation but, contrary to ACh, causes positive chronotropic effects as a result of binding to cardiac receptors which stimulate adenylate cyclase, and thus has been implicated in vagal tachycardias. Since the rate of diastolic depolarization of sinoatrial (SA) node myocytes depends on the hyperpolarization-activated current (if), which is directly activated by cytoplasmic cAMP, we studied the action of VIP on if in myocytes isolated from the SA node of the rabbit. VIP (0.65 microM) reversibly increased if at -65 mV but had no effect at -115 mV suggesting that its primary effect was to shift the activation curve to more positive voltages. Hyperpolarizing ramp and voltage compensation protocols indicated that VIP shifts the activation curve of if by approximately 5-6 mV in the positive direction with no change in maximal conductance. This shift may be the mechanism by which VIP produces its positive chronotropic effect and supports a negative feedback role for this peptide during elevated vagal activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596736     DOI: 10.1007/bf02253849

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  7 in total

1.  Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node.

Authors:  D DiFrancesco; A Ferroni; M Mazzanti; C Tromba
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

2.  Modulation of single hyperpolarization-activated channels (i(f)) by cAMP in the rabbit sino-atrial node.

Authors:  D DiFrancesco; M Mangoni
Journal:  J Physiol       Date:  1994-02-01       Impact factor: 5.182

3.  Muscarinic modulation of cardiac rate at low acetylcholine concentrations.

Authors:  D DiFrancesco; P Ducouret; R B Robinson
Journal:  Science       Date:  1989-02-03       Impact factor: 47.728

4.  Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT.

Authors:  D F Rigel
Journal:  Am J Physiol       Date:  1988-08

5.  Frequency dependence of vasoactive intestinal polypeptide release and vagally induced tachycardia in the canine heart.

Authors:  M R Hill; D W Wallick; P J Martin; M N Levy
Journal:  J Auton Nerv Syst       Date:  1993-05

6.  Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.

Authors:  J Christophe; M Waelbroeck; P Chatelain; P Robberecht
Journal:  Peptides       Date:  1984 Mar-Apr       Impact factor: 3.750

7.  Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nerves.

Authors:  E Weihe; M Reinecke; W G Forssmann
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

  7 in total
  3 in total

1.  Differential control of the hyperpolarization-activated current (i(f)) by cAMP gating and phosphatase inhibition in rabbit sino-atrial node myocytes.

Authors:  E A Accili; G Redaelli; D DiFrancesco
Journal:  J Physiol       Date:  1997-05-01       Impact factor: 5.182

2.  Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide.

Authors:  Analyne Schroeder; Dawn H Loh; Maria C Jordan; Kenneth P Roos; Christopher S Colwell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

Review 3.  Neurohumoral Control of Sinoatrial Node Activity and Heart Rate: Insight From Experimental Models and Findings From Humans.

Authors:  Eilidh A MacDonald; Robert A Rose; T Alexander Quinn
Journal:  Front Physiol       Date:  2020-03-03       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.